Janus Henderson Group PLC Ginkgo Bioworks Holdings, Inc. Transaction History

Janus Henderson Group PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.28 - $1.16 $1,905 - $7,893	-6,805 Reduced 1.16%	581,384 $191,000
Q1 2024 May 15, 2024	BUY	$1.06 - $1.67 $272 - $429	257 Added 0.04%	588,189 $682,000
Q4 2023 Feb 14, 2024	SELL	$1.26 - $1.79 $1,140 - $1,619	-905 Reduced 0.15%	587,932 $993,000
Q3 2023 Nov 14, 2023	BUY	$1.61 - $2.54 $329,043 - $519,112	204,375 Added 53.16%	588,837 $1.07 Million
Q2 2023 Aug 14, 2023	SELL	$1.14 - $1.95 $804 - $1,376	-706 Reduced 0.18%	384,462 $715,000
Q1 2023 May 15, 2023	BUY	$1.2 - $2.19 $238,705 - $435,636	198,921 Added 106.8%	385,168 $512,000
Q4 2022 Feb 14, 2023	BUY	$1.63 - $3.52 $100,701 - $217,465	61,780 Added 49.64%	186,247 $314,000
Q3 2022 Nov 14, 2022	SELL	$0.73 - $3.74 $75 - $385	-103 Reduced 0.08%	124,467 $389,000
Q2 2022 Aug 15, 2022	BUY	$2.2 - $4.2 $274,054 - $523,194	124,570 New	124,570 $297,000

48.4M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.25B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.